Thank you, Mr. Speaker. Mr. Speaker, drug coverage under the Extended Health Benefits program for specified disease conditions has evolved over time. With regard to mental health, which is the issue the Member is raising, the only reference within the GNWT Extended Health Benefits Policy to cover conditions is chronic psychosis. Within this broad category of chronic psychosis, there are a number of specified conditions that are open to interpretation and application to a number of specific conditions.

I would add, however, that this approach to extended health benefits is clearly dated, as eligibility for programs is based on a list of specified conditions rather than based on the clinical and/or financial need of the individual or family. Members may recall that there have been two previous attempts to review the approach to supplementary health benefits. Both were not successful. The last attempt was in 2010-2011, during the 16th Assembly.

I recognize, and the department recognizes, that there is a need to review and update the approach to supplemental health benefits, and it is in its initial stages of updating some inter-jurisdictional research to inform a review, with the intention of moving this project forward in 2018.